by The RxPx Team | Jul 17, 2026 | Articles
Every pharmaceutical launch is measured against ambitious commercial forecasts. Brand teams spend years preparing for approval, market access, and physician uptake. Pharma invests upwards of $1-2 billion and 10+ years to bring a therapy to market. Yet once approved,... by The RxPx Team | Jul 7, 2026 | Articles
How Do We Embrace AI Without Compromising Ethics, Governance, and Trust? That was the central question explored during Medicines Australia’s recent webinar, Conversations & The Code: Compliance and Decision Making – Navigating AI and Emerging... by The RxPx Team | May 26, 2026 | Articles
At Asembia AXS26, one message surfaced repeatedly across conversations with manufacturers, specialty pharmacies, hubs, and patient support leaders: healthcare fragmentation is becoming impossible to ignore. Disconnected systems, siloed vendors, fragmented patient... 